SHAUNA BINETTE: Open Payments
NPI 1427043496 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,523 in 120 payments from 19 companies in 2025. Trend: 2023 $2,182 · 2024 $2,058 · 2025 $2,523
Food & beverage: $2,438Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $654 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $263 |
| GENZYME CORPORATION | 10 | $255 |
| Ipsen Biopharmaceuticals, Inc | 10 | $229 |
| Gilead Sciences, Inc. | 12 | $214 |
| Madrigal Pharmaceuticals | 5 | $196 |
| Janssen Biotech, Inc. | 8 | $190 |
| Ardelyx, Inc. | 4 | $94 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
Products named: RINVOQ, DUPIXENT, ENTYVIO, IQIRVO, LINZESS, REZDIFFRA, TREMFYA, IBSRELA.
Industry payments across AZ — which companies pay providers there.
